Published in Sci Rep on September 04, 2014
Downregulation of miRNA-424: a sign of field cancerisation in clinically normal tongue adjacent to squamous cell carcinoma. Br J Cancer (2015) 0.79
Identification of a six microRNA signature as a novel potential prognostic biomarker in patients with head and neck squamous cell carcinoma. Oncotarget (2016) 0.76
Common SNP in hsa-miR-196a-2 increases hsa-miR-196a-5p expression and predisposes to idiopathic male infertility in Chinese Han population. Sci Rep (2016) 0.76
Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (1999) 83.27
A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol (2010) 22.10
A microRNA component of the p53 tumour suppressor network. Nature (2007) 19.25
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (2011) 11.12
The molecular biology of head and neck cancer. Nat Rev Cancer (2010) 9.84
miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res (2008) 8.97
p53 enters the microRNA world. Cancer Cell (2007) 3.78
The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity (2009) 3.58
MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem (2010) 2.85
TransmiR: a transcription factor-microRNA regulation database. Nucleic Acids Res (2009) 2.80
Identification of high-quality cancer prognostic markers and metastasis network modules. Nat Commun (2010) 2.54
Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene (2002) 2.50
TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. IARC Sci Publ (2004) 2.23
DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpoint. Genes Dev (2006) 1.96
PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes. Genome Biol (2010) 1.79
Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. Nat Commun (2013) 1.62
miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate (2010) 1.55
Optimally weighted Z-test is a powerful method for combining probabilities in meta-analysis. J Evol Biol (2011) 1.52
AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist. Proc Natl Acad Sci U S A (2009) 1.43
MicroRNA regulation and interspecific variation of gene expression. Trends Genet (2007) 1.39
MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL. Carcinogenesis (2012) 1.39
Projections of number of cancer cases in India (2010-2020) by cancer groups. Asian Pac J Cancer Prev (2010) 1.37
Redefining the p53 response element. Proc Natl Acad Sci U S A (2009) 1.36
DNA methylation biomarkers for lung cancer. Tumour Biol (2011) 1.35
Constructing biological networks through combined literature mining and microarray analysis: a LMMA approach. Bioinformatics (2006) 1.33
CpG island methylation profiling in human salivary gland adenoid cystic carcinoma. Cancer (2011) 1.21
Akt versus p53 in a network of oncogenes and tumor suppressor genes regulating cell survival and death. Biophys J (2006) 1.20
OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway. Cell Death Dis (2013) 1.20
MEIS and PBX homeobox proteins in ovarian cancer. Eur J Cancer (2007) 1.19
p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma. Oral Oncol (2010) 1.10
The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32. Genomics (2001) 1.05
Down-regulation of miR-150 induces cell proliferation inhibition and apoptosis in non-small-cell lung cancer by targeting BAK1 in vitro. Tumour Biol (2014) 1.00
microRNA evolution in a human transcription factor and microRNA regulatory network. BMC Syst Biol (2010) 0.99
Deregulation of a Hox protein regulatory network spanning prostate cancer initiation and progression. Clin Cancer Res (2012) 0.98
TP53 mutations in favorable-risk Wnt/Wingless-subtype medulloblastomas. J Clin Oncol (2011) 0.96
A miR-centric view of head and neck cancers. Biochim Biophys Acta (2011) 0.95
Risk genes in head and neck cancer: a systematic review and meta-analysis of last 5 years. Oral Oncol (2013) 0.94
Dynamic modeling and analysis of cancer cellular network motifs. Integr Biol (Camb) (2011) 0.90
Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients. J Oral Pathol Med (2009) 0.89
A review of the relationship between alcohol and oral cancer. Surgeon (2011) 0.89
Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Clin Cancer Res (1999) 0.88
Polymorphism in the thymidylate synthase promoter enhancer region is not an efficacious marker for tumor sensitivity to 5-fluorouracil-based oral adjuvant chemotherapy in colorectal cancer. Clin Cancer Res (2003) 0.88
Two proliferation-related proteins, TYMS and PGK1, could be new cytotoxic T lymphocyte-directed tumor-associated antigens of HLA-A2+ colon cancer. Clin Cancer Res (2004) 0.86
Tumor suppressor p53 (TP53) at the crossroads of the exposome and the cancer genome. Proc Natl Acad Sci U S A (2012) 0.84
MicroRNA networks alter to conform to transcription factor networks adding redundancy and reducing the repertoire of target genes for coordinated regulation. Mol Biol Evol (2010) 0.84
Association between dietary folate intake and clinical outcome in head and neck squamous cell carcinoma. Ann Oncol (2011) 0.83
Thymidylate synthase gene (TYMS) polymorphisms in sporadic and hereditary breast cancer. BMC Res Notes (2012) 0.81
HNOCDB: a comprehensive database of genes and miRNAs relevant to head and neck and oral cancer. Oral Oncol (2011) 0.81
The homeobox gene MEIS1 is methylated in BRAF (p.V600E) mutated colon tumors. PLoS One (2013) 0.81
A product of the bicistronic Drosophila melanogaster gene CG31241, which also encodes a trimethylguanosine synthase, plays a role in telomere protection. J Cell Sci (2009) 0.79
Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway. Br J Cancer (2012) 0.79
Genetic variations and head and neck cancer risks. Mol Biol Rep (2014) 0.78
Changes in expression of oncogenes and TP53 tumour suppressor gene as biomarkers in head and neck cancers. Eur Arch Otorhinolaryngol (2010) 0.78
Association between polymorphisms of the renin-angiotensin system genes and breast cancer risk: a meta-analysis. Breast Cancer Res Treat (2011) 0.78
Associating functional groups to multiple clinical types using combined t-test scores and contingency-based measures: a study on breast cancer genes. Int J Comput Biol Drug Des (2012) 0.76
Thymidylate synthetase allelic imbalance in clear cell renal carcinoma. Cancer Chemother Pharmacol (2009) 0.76